📗 Cite This Artifact
REG3A Protein
REG3A Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">REG3A Protein</th>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Amyloid-beta</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Bacterial peptidoglycan</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">C-type lectin receptors</td>
<td>Unknown</td>
</tr>
<tr>
<td class="label">EGFR</td>
<td>Transactivation</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
REG3A (Regenerating Islet-Derived Protein 3 Alpha), also known as HIP/PAP (Hepatocarcinoma-Intestine-Pancreas/Pancreatitis-Associated Protein), is a member of the Reg family of C-type lectins. This 16 kDa secreted protein is primarily expressed in the pancreas, gastrointestinal tract, and liver, where it plays important roles in tissue regeneration, cell proliferation, and innate immunity. Originally identified as a pancreatitis-associated protein, REG3A has emerged as a multifunctional molecule with significant implications for neurobiology and regenerative medicine.
REG3A Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">REG3A Protein</th>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Amyloid-beta</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Bacterial peptidoglycan</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">C-type lectin receptors</td>
<td>Unknown</td>
</tr>
<tr>
<td class="label">EGFR</td>
<td>Transactivation</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
REG3A (Regenerating Islet-Derived Protein 3 Alpha), also known as HIP/PAP (Hepatocarcinoma-Intestine-Pancreas/Pancreatitis-Associated Protein), is a member of the Reg family of C-type lectins. This 16 kDa secreted protein is primarily expressed in the pancreas, gastrointestinal tract, and liver, where it plays important roles in tissue regeneration, cell proliferation, and innate immunity. Originally identified as a pancreatitis-associated protein, REG3A has emerged as a multifunctional molecule with significant implications for neurobiology and regenerative medicine.
The REG (Regenerating) family consists of several structurally related proteins (REG1A, REG1B, REG3A, REG3B, REG3G, REG4) that share a conserved C-type lectin domain. REG3A stands out due to its specific binding to bacterial peptidoglycans and its expression in both peripheral organs and the central nervous system, making it uniquely positioned to bridge systemic and neural functions.
Gene and Protein Structure
REG3A Gene
The REG3A gene is located on chromosome 2p12 in humans and encodes a precursor protein of 175 amino acids. The gene structure includes:
- Location: 2p12
- Gene size: ~2.5 kb
- Exons: 6
- Alternative names: REG3, HIPPAP, PAP1, UNQ429
The gene encodes a preproprotein that undergoes:
This processing yields the mature secreted protein of approximately 16 kDa.
Protein Architecture
REG3A exhibits a classic C-type lectin fold with several distinctive features:
- Carbohydrate recognition domain (CRD)
- Calcium-dependent binding site
- EPN (Glu-Pro-Asn) motif characteristic of mannose-binding lectins
Structural Studies
X-ray crystallography and NMR studies have revealed:
- Overall fold similar to other C-type lectins
- Dimeric or hexameric quaternary structure
- Carbohydrate-binding pocket on the surface
- Flexibility in the N-terminal region
Expression and Distribution
Peripheral Tissue Expression
REG3A exhibits a tissue-specific expression pattern:
High expression:
- Pancreas (acinar cells, islets)
- Gastrointestinal tract (stomach, small intestine, colon)
- Liver (hepatocytes)
- Submandibular glands
- Kidney
- Lung
- Spleen
- Lymph nodes
- Heart
- Brain (under specific conditions)
- Adipose tissue
Regulation of Expression
REG3A expression is regulated by multiple factors:
Nervous System Expression
While REG3A is not a classic neuronal protein, evidence shows:
Biological Functions
Antimicrobial Activity
One of REG3A's primary functions is host defense:
The EPN motif in REG3A's CRD determines its mannose/glucose specificity, which is relevant for bacterial recognition as many bacterial cell wall components contain mannose-rich structures.
Tissue Regeneration and Cell Proliferation
REG3A promotes cell proliferation and tissue repair:
The mechanisms include:
- Autocrine and paracrine signaling
- Activation of EGFR and downstream pathways
- STAT3 phosphorylation
- Cell cycle regulation
Acute-Phase Response
As an acute-phase protein, REG3A participates in the systemic inflammatory response:
Anti-inflammatory Properties
Despite being an acute-phase protein, REG3A has anti-inflammatory effects:
Role in Neurodegenerative Diseases
Alzheimer's Disease
REG3A has emerged as a potentially important player in AD pathogenesis:
Mechanistic insights:
- REG3A protects against Aβ-induced toxicity in neurons
- Reduces oxidative stress in Aβ-treated cells
- Modulates neuroinflammation
- May promote Aβ clearance
The relationship between REG3A and Aβ appears complex. While REG3A can bind Aβ in vitro, the functional consequences of this interaction are still being elucidated. Some studies suggest REG3A may facilitate Aβ aggregation into less toxic species, while others indicate it promotes Aβ clearance through phagocytosis.
Evidence from studies:
- Reduced REG3A in AD hippocampus
- REG3A protects neurons from Aβ toxicity
- REG3A modulates microglial activation
- Genetic variants in REG3A may influence AD risk
Parkinson's Disease
In Parkinson's disease models, REG3A shows:
Mechanisms:
- Anti-apoptotic effects via cAMP/PKA pathway
- Antioxidant properties
- Mitochondrial protection
- Neuroinflammation modulation
Stroke and Cerebral Ischemia
REG3A is upregulated following cerebral ischemia:
Neuroprotective mechanisms:
- Anti-apoptotic signaling
- Anti-inflammatory effects
- Promotion of angiogenesis
- Support of neural progenitor cells
- Recombinant REG3A administration
- Gene therapy approaches
- Small molecule activators
Multiple Sclerosis
In demyelinating conditions:
Amyotrophic Lateral Sclerosis (ALS)
Emerging evidence suggests:
Molecular Mechanisms
Signaling Pathways
REG3A engages multiple signaling cascades:
- Increases intracellular cAMP
- Activates PKA
- Anti-apoptotic effects
- Cell proliferation
- Activation of ERK1/2
- Cell growth and survival
- Differentiation
- Cell survival signaling
- Anti-apoptotic
- Metabolic regulation
- Particularly in inflammation
- Acute-phase response
Receptor-Mediated Signaling
While REG3A lacks a classic receptor, it may signal through:
Interaction with Other Proteins
REG3A interacts with various proteins:
Therapeutic Implications
Drug Development
REG3A-based therapeutic strategies include:
Biomarker Potential
REG3A may serve as a biomarker:
Clinical Applications
Potential clinical uses include:
- Acute pancreatitis treatment
- Stroke neuroprotection
- Alzheimer's disease intervention
- Diabetes management (beta-cell regeneration)
- Wound healing promotion
Research Methods
Model Systems
- Cell lines: MIN6, HIT, RIN for pancreatic studies
- Primary neurons: For neuroprotection studies
- Animal models: Mouse models of pancreatitis, AD, PD, stroke
- Patient samples: Brain tissue, CSF, plasma
Key Techniques
- ELISA for protein detection
- Immunohistochemistry
- Western blotting
- qRT-PCR for expression
- Cell viability assays
- Calcium imaging
- Behavioral testing in animal models
Cross-links
- [REG3A Gene](/genes/reg3a)
- [REG3G Protein](/proteins/reg3g-protein)
- [REG1A Protein](/proteins/reg1a-protein)
- [GDNF Protein](/proteins/gdnf-protein)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Stroke](/diseases/stroke)
See Also
- [C-Type Lectins](/mechanisms/c-type-lectin-signaling)
- [Acute-Phase Proteins](/mechanisms/acute-phase-response)
- [Tissue Regeneration](/mechanisms/tissue-regeneration)
- [Neuroprotection](/mechanisms/neuroprotection-mechanisms)
- [Beta-Cell Regeneration](/mechanisms/beta-cell-regeneration)
- [Innate Immunity](/mechanisms/innate-immunity)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-reg3a-protein |
| kg_node_id | REG3APROTEIN |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-ec5b8f0b5027 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-reg3a-protein'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-reg3a-protein?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[REG3A Protein](http://scidex.ai/artifact/wiki-proteins-reg3a-protein)
http://scidex.ai/artifact/wiki-proteins-reg3a-protein